Only this time the antigen is whole and B cells don't keep it to themselves. The BCR- and TCR-mediated immunological synapses are strikingly similar in terms of antigen receptor recruitment ...

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection) for use in patients with prostate cancer.

TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...

Suspected recurrent PCa in patients with increasing levels of serum prostate-specific antigen (PSA) after primary curative therapy ... as the standard of care after initial diagnosis and biochemical ...